Skip to content

Study of Comparison of Carbetocin with Oxytocin in their efficiency to prevent Blood loss following delivery in Patients Undergoing Caesarean Section

Comparative Study of Carbetocin Vs Oxytocin in Primary PPH Prophylaxis in Patients Undergoing Caesarean Section at a Tertiary Care Center

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2022/07/043990
Enrollment
106
Registered
2022-07-13
Start date
Unknown
Completion date
Unknown
Last updated
2022-08-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O720- Third-stage hemorrhage

Interventions

Intervention1: Uterotonic drug given after delivery of baby in patients undergoing caesarean section: Comparative drugs oxytocin and carbetocin will be given after delivery of baby in patients undergo

Sponsors

Dr S N medical college Jodhpur
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Primigravida patients with term, singleton pregnancy undergoing caesarean section will be included

Exclusion criteria

Exclusion criteria: 1. Patients refusing consent. 2. Patients with multifetal gestation. 3. Multigravida patients. 4. Patients with antepartum haemorhhage. 5. Patients with any known coagulation disorders, hepatic, renal, cardiac disorder. 6. Patients developing PPH where etiology is other than being atonic. 7. Patients with any known allergy/ found allergic to oxytocin or carbetocin.

Design outcomes

Primary

MeasureTime frame
To compare the incidence of primary PPH in patients undergoing caesarean section receiving oxytocin with those receiving carbetocinTimepoint: 24 hours

Secondary

MeasureTime frame
1. To compare mean difference in pre-op and post-op Hb and hct levels 2. To compare need for additional uterotonic agents 3. To compare need for blood transfusionTimepoint: 24 hours

Countries

India

Contacts

Public ContactDr B S Jodha

Dr. S N Medical college Jodhpur

jodha.bs27@gmail.com

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026